EV/EBITDA
-2.90
-0.08-2.84%
1 min ago
Summary
- As of February 26, 2025, ACRS EV/EBITDA is -2.90, with a fall of -0.08 (-2.84%) during the most recent trading day.
- Over the past year, ACRS EV/EBITDA has dropped by -2.47 (-574.42%).
- ACRS EV/EBITDA is now -9766.67% below its all-time high of 0.03.
Performance
ACRS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ACRS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.8% | +2.8% | +2.2% |
| 1 m1 month | +19.7% | -19.6% | -16.1% |
| 3 m3 months | +48.5% | -48.5% | -42.6% |
| 6 m6 months | -267.1% | +176.6% | +72.5% |
| ytdytd | +18.1% | -18.0% | -14.8% |
| 1 y1 year | -574.4% | +261.0% | +68.4% |
| 5 y5 years | -1281.0% | +913.2% | +71.1% |
ACRS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.8% | -3.76 | +22.9% | |
| 3 m | 3-month | -2.82 | -2.8% | -6.33 | +54.2% |
| 6 m | 6-month | -0.56 | -417.9% | -7.25 | +60.0% |
| 1 y | 1-year | -0.36 | -705.6% | -7.25 | +60.0% |
| 3 y | 3-year | -0.06 | -4733.3% | -16.62 | +82.5% |
| 5 y | 5-year | 0.03 | -9766.7% | -33.44 | +91.3% |
| alltime | all time | 0.03 | -9766.7% | -33.44 | +91.3% |
Aclaris Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.90(-18.1%) |
| 2024 | -3.54(+1006.3%) |
| 2023 | -0.32(-97.3%) |
| 2022 | -11.92(-11.0%) |
| 2021 | -13.40(+123.0%) |
| Date | Value |
|---|---|
| 2020 | -6.01(+1034.0%) |
| 2019 | -0.53(-79.7%) |
| 2018 | -2.61(-81.3%) |
| 2017 | -13.99(-0.5%) |
| 2016 | -14.06(-45.7%) |
| 2015 | -25.91 |
FAQ
- What is Aclaris Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Aclaris Therapeutics?
- What is ACRS EV/EBITDA year-to-date change?
- What is Aclaris Therapeutics EV/EBITDA year-on-year change?
What is Aclaris Therapeutics EV/EBITDA?
The current EV/EBITDA of ACRS is -2.90
What is the all time high EV/EBITDA for Aclaris Therapeutics?
Aclaris Therapeutics all-time high EV/EBITDA is 0.03
What is ACRS EV/EBITDA year-to-date change?
Aclaris Therapeutics EV/EBITDA has changed by +0.64 (+18.08%) since the beginning of the year
What is Aclaris Therapeutics EV/EBITDA year-on-year change?
Over the past year, ACRS EV/EBITDA has changed by -2.47 (-574.42%)